Words of Wisdom:

"imagination is key, but the stars create imagination! (daaaaa crab!)" - Ytiema

Jsb Market Research - Pharmapoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

  • Date Submitted: 06/07/2014 03:46 AM
  • Flesch-Kincaid Score: 32.7 
  • Words: 4129
  • Essay Grade: no grades
  • Report this Essay
MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

Released On 7th June 2014

A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market. This report analyses companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion diagnostic tests. This report focuses on the major test kits that are supplied to pathology laboratories.

Buy this report OR Know more : http://www.jsbmarketresearch.com/healthcare-medical/r-MediPoint-Companion-Diagnostic-Tests-in-Oncology-Global-Analysis-and-Market-Forecasts-110214

Highlights

Key Questions Answered

- Global cancer incidence is expected to rise. (Q).What role will companion diagnostic tests for play in the forecast period to tackle this global issue? (Q).How many procedures of companion diagnostic tests will be performed in the ten major markets covered in the report?
- What are the reasons to develop a Companion Diagnostic Test. (Q).What motivates companies to develop a companion diagnostic; physician demand or legislative requirement?
- What strategies are adopted in developing a new companion diagnostics test. (Q).When and how is a companion diagnostic test developed? (Q).Who are the stakeholders? (Q).What are the relationships between Big Pharma and Diagnostic test developers?
- (Q).What technologies...

Comments

Express your owns thoughts and ideas on this essay by writing a grade and/or critique.

  1. No comments